Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle C Cuneo

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 1, 2006
SRC family kinase inhibitor SU6656 enhances antiangiogenic effect of irradiationKyle C Cuneo, Ling Geng, Jiahuai Tan, et al.
Journal of Proteome Research|February 28, 2017
Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing ChemoradiotherapyMingrui An, Ines Lohse, Zhijing Tan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 13, 2017
Prognostic Value of c-MET Expression in Patients With Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation TherapyKyle C Cuneo, Meredith A Morgan, Kent A Griffith, et al.
Advances in Radiation Oncology|December 4, 2023
Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic CancerRishi Das, Madeline R Abbott, Scott W Hadley, et al.
International Journal of Radiation Oncology, Biology, Physics|March 16, 2016
Wee1 Kinase Inhibitor AZD1775 Radiosensitizes Hepatocellular Carcinoma Regardless of TP53 Mutational Status Through Induction of Replication StressKyle C Cuneo, Meredith A Morgan, Mary A Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2018
Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic MetastasesWilliam C Jackson, Yebin Tao, Mishal Mendiratta-Lala, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2013
Imaging primary mouse sarcomas after radiation therapy using cathepsin-activatable fluorescent imaging agentsKyle C Cuneo, Jeffrey K Mito, Melodi P Javid, et al.
Medical Physics|September 24, 2017
Improved quantitative <sup>90</sup> Y bremsstrahlung SPECT/CT reconstruction with Monte Carlo scatter modelingYuni K Dewaraja, Se Young Chun, Ravi N Srinivasa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2021
Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of HepatotoxicityMatthew M Cousins, Theresa P Devasia, Christopher M Maurino, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2011
Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomasKyle C Cuneo, James J Vredenburgh, John H Sampson, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|March 1, 2006
SRC family kinase inhibitor SU6656 enhances antiangiogenic effect of irradiationKyle C Cuneo, Ling Geng, Jiahuai Tan, et al.
Journal of Proteome Research|February 28, 2017
Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing ChemoradiotherapyMingrui An, Ines Lohse, Zhijing Tan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 13, 2017
Prognostic Value of c-MET Expression in Patients With Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation TherapyKyle C Cuneo, Meredith A Morgan, Kent A Griffith, et al.
Advances in Radiation Oncology|December 4, 2023
Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic CancerRishi Das, Madeline R Abbott, Scott W Hadley, et al.
International Journal of Radiation Oncology, Biology, Physics|March 16, 2016
Wee1 Kinase Inhibitor AZD1775 Radiosensitizes Hepatocellular Carcinoma Regardless of TP53 Mutational Status Through Induction of Replication StressKyle C Cuneo, Meredith A Morgan, Mary A Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2018
Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic MetastasesWilliam C Jackson, Yebin Tao, Mishal Mendiratta-Lala, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2013
Imaging primary mouse sarcomas after radiation therapy using cathepsin-activatable fluorescent imaging agentsKyle C Cuneo, Jeffrey K Mito, Melodi P Javid, et al.
Medical Physics|September 24, 2017
Improved quantitative <sup>90</sup> Y bremsstrahlung SPECT/CT reconstruction with Monte Carlo scatter modelingYuni K Dewaraja, Se Young Chun, Ravi N Srinivasa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2021
Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of HepatotoxicityMatthew M Cousins, Theresa P Devasia, Christopher M Maurino, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2011
Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomasKyle C Cuneo, James J Vredenburgh, John H Sampson, et al.
Pageof 8